An Observational Study of Patients With Malignant Lymphomas Treated With MabThera SC in Everyday Clinical Practice.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 23 Mar 2017
At a glance
- Drugs Rituximab (Primary)
- Indications Diffuse large B cell lymphoma; Follicular lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Sponsors Roche
- 07 Jun 2017 Biomarkers information updated
- 20 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 04 Nov 2016 Planned End Date changed from 1 Dec 2018 to 1 Jul 2019.